Andrea Charles | 12/15/2011
How is the industry seeking to understanding DDI with a view to better prediction and control? How has the current technology landscape changed following the publication of the ITC white paper? What progress do you expect we will see in clinically relevant drug transporters in 2012? Drug transporters exert a vital influence on drug absorption, disposition, metabolism and elimination and are seen as an essential part of predicting drug disposition. However, identifying and employ...
To continue reading this story Click Here
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
Pharma Contract Manufacturing
23 - 25 March 2026
Mercure Hotel MOA Berlin, Germany
Register Now |
View Agenda |
Learn More